{"id":2371,"date":"2022-10-25T10:54:37","date_gmt":"2022-10-25T08:54:37","guid":{"rendered":"http:\/\/grupo.us.es\/healthterritory\/?p=2371"},"modified":"2022-10-25T10:54:37","modified_gmt":"2022-10-25T08:54:37","slug":"gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2","status":"publish","type":"post","link":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/","title":{"rendered":"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1)"},"content":{"rendered":"<h2><strong>Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) <\/strong><\/h2>\n<p>Stephanie Rose Harrison, Marco Garrido-Cumbrera, Victoria Navarro-Comp\u00e1n, Jos\u00e9 Correa-Fern\u00e1ndez, Dale Webb, Laura Christen and Helena Marzo-Ortega<\/p>\n<p>Rheumatology Advances in Practice. 2021<\/p>\n<h3 class=\"c-article__sub-heading\" style=\"text-align: justify;\" data-test=\"abstract-sub-heading\"><strong>Objective<\/strong><\/h3>\n<p style=\"text-align: justify;\">The aim was to compare the impact of the first wave of the coronavirus disease 2019 (COVID-19) pandemic and lockdown measures on patients with rheumatic and musculoskeletal diseases (RMDs) in the UK and other European countries (OEC).<\/p>\n<h3 class=\"c-article__sub-heading\" style=\"text-align: justify;\" data-test=\"abstract-sub-heading\"><strong>Methods<\/strong><\/h3>\n<p>REUMAVID was an online cross-sectional survey of seven European countries. The data collected included the following: demographics, lifestyle, employment, access to health-care services, disease-specific characteristics, the World Health Organization five well-being index (WHO-5), hospital anxiety and depression scale (HADS), visual analogue scale (VAS) disease activity, and the perceived acceptable symptom scale.<\/p>\n<h3 class=\"c-article__sub-heading\" style=\"text-align: justify;\" data-test=\"abstract-sub-heading\"><strong>Results<\/strong><\/h3>\n<p style=\"text-align: justify;\">One thousand eight hundred responses were received between April and July 2020 [UK, n = 558 (31.0%); OEC, n = 1242 (69.0%)]. UK patients were more likely to be older [mean (S.d.): UK 58.5 (13.4) years; OEC 50.0 (12.2) years], university educated [UK n = 302 (54.1%); OEC n = 572 (46.1%), quit smoking [UK n = 92 (59.4%); OEC n = 65 (16.2%)] and continue exercise [UK, n = 216 (49.2%); OEC, n = 228 (33.1%)], although, conversely, alcohol consumption increased [UK n = 99 (36.3%); OEC n = 98 (12.1%)]. UK patients felt informed about COVID-19 (UK 72.7%, OEC 57.4%) and kept their planned rheumatology [UK n = 87 (51.2%); OEC n = 213 (38.6%)] and\/or general practice appointments [UK n = 87 (76.3%); OEC n = 310 (53.9%)]. Almost half the patients with RMDs reported a decline in health and well-being, although this was less common in UK patients [UK n = 214 (38.4%), OEC n = 618 (50.2%)], who reported better perceived acceptable symptom scale, VAS pain and HADS scores, but worse WHO-5 scores.<\/p>\n<h3 class=\"c-article__sub-heading\" style=\"text-align: justify;\" data-test=\"abstract-sub-heading\"><strong>Conclusion<\/strong><\/h3>\n<p style=\"text-align: justify;\">UK RMD patients performed better in the physical and mental health domains tested, possibly owing to a less restrictive lockdown and better health-care access. These findings have implications for health-care services globally in planning patient care after the COVID-19 pandemic.<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Enlace al art\u00edculo:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34988357\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34988357\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) Stephanie Rose Harrison, Marco Garrido-Cumbrera, Victoria Navarro-Comp\u00e1n, Jos\u00e9 Correa-Fern\u00e1ndez, Dale Webb, Laura Christen and Helena Marzo-Ortega Rheumatology Advances in Practice. 2021 Objective The aim was to compare the impact of the first wave&hellip;<\/p>\n","protected":false},"author":7,"featured_media":2372,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[50],"tags":[],"class_list":["post-2371","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articulos","category-50","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) - Health &amp; Territory Research<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) - Health &amp; Territory Research\" \/>\n<meta property=\"og:description\" content=\"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) Stephanie Rose Harrison, Marco Garrido-Cumbrera, Victoria Navarro-Comp\u00e1n, Jos\u00e9 Correa-Fern\u00e1ndez, Dale Webb, Laura Christen and Helena Marzo-Ortega Rheumatology Advances in Practice. 2021 Objective The aim was to compare the impact of the first wave&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Health &amp; Territory Research\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-25T08:54:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/grupo.us.es\/newthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1641\" \/>\n\t<meta property=\"og:image:height\" content=\"774\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Jos\u00e9 Correa Fern\u00e1ndez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jos\u00e9 Correa Fern\u00e1ndez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/\",\"name\":\"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) - Health &amp; Territory Research\",\"isPartOf\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png\",\"datePublished\":\"2022-10-25T08:54:37+00:00\",\"author\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b\"},\"breadcrumb\":{\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#primaryimage\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png\",\"contentUrl\":\"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png\",\"width\":1641,\"height\":774},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/grupo.us.es\/newthterritory\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#website\",\"url\":\"https:\/\/grupo.us.es\/healthterritory\/\",\"name\":\"Health &amp; Territory Research\",\"description\":\"Interdisciplinary Research Group of the University of Seville\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/grupo.us.es\/healthterritory\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b\",\"name\":\"Jos\u00e9 Correa Fern\u00e1ndez\",\"sameAs\":[\"http:\/\/grupo.us.es\/healthterritory\/\"],\"url\":\"https:\/\/grupo.us.es\/healthterritory\/author\/pepe\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) - Health &amp; Territory Research","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/","og_locale":"es_ES","og_type":"article","og_title":"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) - Health &amp; Territory Research","og_description":"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) Stephanie Rose Harrison, Marco Garrido-Cumbrera, Victoria Navarro-Comp\u00e1n, Jos\u00e9 Correa-Fern\u00e1ndez, Dale Webb, Laura Christen and Helena Marzo-Ortega Rheumatology Advances in Practice. 2021 Objective The aim was to compare the impact of the first wave&hellip;","og_url":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/","og_site_name":"Health &amp; Territory Research","article_published_time":"2022-10-25T08:54:37+00:00","og_image":[{"width":1641,"height":774,"url":"https:\/\/grupo.us.es\/newthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png","type":"image\/png"}],"author":"Jos\u00e9 Correa Fern\u00e1ndez","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Jos\u00e9 Correa Fern\u00e1ndez","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/","url":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/","name":"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1) - Health &amp; Territory Research","isPartOf":{"@id":"https:\/\/grupo.us.es\/healthterritory\/#website"},"primaryImageOfPage":{"@id":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#primaryimage"},"image":{"@id":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#primaryimage"},"thumbnailUrl":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png","datePublished":"2022-10-25T08:54:37+00:00","author":{"@id":"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b"},"breadcrumb":{"@id":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#primaryimage","url":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png","contentUrl":"https:\/\/grupo.us.es\/healthterritory\/wp-content\/uploads\/2022\/10\/uk-vs-rest.png","width":1641,"height":774},{"@type":"BreadcrumbList","@id":"https:\/\/grupo.us.es\/healthterritory\/gender-differences-in-patient-journey-to-diagnosis-and-diseaseoutcomes-results-from-the-european-map-of-axial-spondyloarthritis-emas-3-2-2-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/grupo.us.es\/newthterritory\/"},{"@type":"ListItem","position":2,"name":"Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase 1)"}]},{"@type":"WebSite","@id":"https:\/\/grupo.us.es\/healthterritory\/#website","url":"https:\/\/grupo.us.es\/healthterritory\/","name":"Health &amp; Territory Research","description":"Interdisciplinary Research Group of the University of Seville","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/grupo.us.es\/healthterritory\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/grupo.us.es\/healthterritory\/#\/schema\/person\/6edfd257e38aaa36b2d51b61392dfb7b","name":"Jos\u00e9 Correa Fern\u00e1ndez","sameAs":["http:\/\/grupo.us.es\/healthterritory\/"],"url":"https:\/\/grupo.us.es\/healthterritory\/author\/pepe\/"}]}},"wps_subtitle":"","_links":{"self":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/comments?post=2371"}],"version-history":[{"count":1,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2371\/revisions"}],"predecessor-version":[{"id":2373,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/posts\/2371\/revisions\/2373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/media\/2372"}],"wp:attachment":[{"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/media?parent=2371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/categories?post=2371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grupo.us.es\/healthterritory\/wp-json\/wp\/v2\/tags?post=2371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}